全文获取类型
收费全文 | 2088篇 |
免费 | 158篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 65篇 |
妇产科学 | 21篇 |
基础医学 | 249篇 |
口腔科学 | 216篇 |
临床医学 | 205篇 |
内科学 | 403篇 |
皮肤病学 | 50篇 |
神经病学 | 224篇 |
特种医学 | 129篇 |
外科学 | 192篇 |
综合类 | 46篇 |
一般理论 | 3篇 |
预防医学 | 103篇 |
眼科学 | 8篇 |
药学 | 182篇 |
中国医学 | 2篇 |
肿瘤学 | 159篇 |
出版年
2021年 | 21篇 |
2019年 | 24篇 |
2018年 | 29篇 |
2017年 | 20篇 |
2016年 | 22篇 |
2014年 | 21篇 |
2013年 | 47篇 |
2012年 | 43篇 |
2011年 | 58篇 |
2010年 | 50篇 |
2009年 | 57篇 |
2008年 | 51篇 |
2007年 | 64篇 |
2006年 | 76篇 |
2005年 | 63篇 |
2004年 | 56篇 |
2003年 | 65篇 |
2002年 | 43篇 |
2001年 | 52篇 |
2000年 | 50篇 |
1999年 | 59篇 |
1998年 | 50篇 |
1997年 | 45篇 |
1996年 | 46篇 |
1995年 | 43篇 |
1994年 | 27篇 |
1993年 | 35篇 |
1992年 | 67篇 |
1991年 | 56篇 |
1990年 | 55篇 |
1989年 | 46篇 |
1988年 | 62篇 |
1987年 | 63篇 |
1986年 | 72篇 |
1985年 | 60篇 |
1984年 | 53篇 |
1983年 | 32篇 |
1982年 | 28篇 |
1981年 | 26篇 |
1980年 | 26篇 |
1979年 | 39篇 |
1978年 | 24篇 |
1977年 | 25篇 |
1976年 | 24篇 |
1975年 | 23篇 |
1974年 | 23篇 |
1973年 | 36篇 |
1972年 | 25篇 |
1971年 | 23篇 |
1970年 | 31篇 |
排序方式: 共有2260条查询结果,搜索用时 31 毫秒
51.
Frank?K.?Brown Farida?Kopti Charlie??Chang Scott?A.?Johnson Meir?Glick Chris?L.?Waller 《The AAPS journal》2017,19(5):1255-1263
Merck & Co., Inc., Kenilworth, NJ, USA, is undergoing a transformation in the way that it prosecutes R&D programs. Through the adoption of a “model-driven” culture, enhanced R&D productivity is anticipated, both in the form of decreased attrition at each stage of the process and by providing a rational framework for understanding and learning from the data generated along the way. This new approach focuses on the concept of a “Design Cycle” that makes use of all the data possible, internally and externally, to drive decision-making. These data can take the form of bioactivity, 3D structures, genomics, pathway, PK/PD, safety data, etc. Synthesis of high-quality data into models utilizing both well-established and cutting-edge methods has been shown to yield high confidence predictions to prioritize decision-making and efficiently reposition resources within R&D. The goal is to design an adaptive research operating plan that uses both modeled data and experiments, rather than just testing, to drive project decision-making. To support this emerging culture, an ambitious information management (IT) program has been initiated to implement a harmonized platform to facilitate the construction of cross-domain workflows to enable data-driven decision-making and the construction and validation of predictive models. These goals are achieved through depositing model-ready data, agile persona-driven access to data, a unified cross-domain predictive model lifecycle management platform, and support for flexible scientist-developed workflows that simplify data manipulation and consume model services. The end-to-end nature of the platform, in turn, not only supports but also drives the culture change by enabling scientists to apply predictive sciences throughout their work and over the lifetime of a project. This shift in mindset for both scientists and IT was driven by an early impactful demonstration of the potential benefits of the platform, in which expert-level early discovery predictive models were made available from familiar desktop tools, such as ChemDraw. This was built using a workflow-driven service-oriented architecture (SOA) on top of the rigorous registration of all underlying model entities. 相似文献
52.
A. Huang N. Fiadorchanka K. Brar J.L. Balderacchi S.A. Glick 《The British journal of dermatology》2017,177(5):1439-1441
Mastocytosis is a clinically heterogenous disease characterized by mast cell hyperplasia in skin, bone marrow and/or visceral organs. Cutaneous mastocytosis is more frequently observed in children, whereas indolent systemic mastocytosis is more commonly observed in adults. Aggressive systemic presentation, particularly of the neonate, is exceptionally rare. We present a rare case of congenital aggressive systemic mastocytosis. The patient was a 37‐week‐old male, born by caesarean section owing to hepatosplenomegaly and ascites diagnosed in utero, who exhibited extensive cutaneous and systemic manifestations of mastocytosis at birth. Mutation analysis of c‐KIT identified D816V mutation in exon 17. Although initial bilateral bone marrow aspirates demonstrated no mast‐cell infiltrates or haematological neoplasm, subsequent bone‐marrow biopsies postmortem exhibited multifocal mast‐cell aggregates. Clinical course was complicated by bacteraemia and cardiorespiratory failure, leading to death at 10 weeks. 相似文献
53.
F. M. L. Pinheiro Júnior C. Kendall T. A. Martins R. M. S. Mota R. H. M. Macena J. Glick 《AIDS care》2016,28(1):92-97
Transwomen are a high-risk population for HIV/AIDS worldwide. However, many transwomen do not test for HIV. This study aimed to identify factors associated with resistance to HIV testing among transwomen in Fortaleza/CE. A cross-sectional study was conducted between August and December 2008 with a sample of 304 transwomen recruited through respondent-driven sampling. Data analysis utilized Respondent-Driven Sampling Analysis Tool and SPSS 11.0. Univariate, bivariate, and multivariate analyses examined risk factors associated with resistance to HIV testing. Less than 18 years of age (OR?=?4.221; CI?=?2.419–7.364), sexual debut before 10 years of age (OR?=?6.760; CI?=?2.996–15.256), using illegal drugs during sex (OR?=?2.384; CI?=?1.310–4.339), experience of discrimination (OR?=?3.962; CI?=?1.540–10.195) and a belief that the test results were not confidential (OR?=?3.763; CI?=?2.118–6.688) are independently associated with resistance to testing. Intersectoral and targeted strategies aimed at encouraging the adoption of safer sexual behaviors and testing for HIV among transwomen are required. 相似文献
54.
Cloned manganese superoxide dismutase reduces oxidative stress in Escherichia coli and Anacystis nidulans. 总被引:6,自引:1,他引:6 下载免费PDF全文
M Y Gruber B R Glick J E Thompson 《Proceedings of the National Academy of Sciences of the United States of America》1990,87(7):2608-2612
The Mn superoxide dismutase gene of Escherichia coli was subcloned into the E. coli-Anacystis nidulans shuttle vector pSG111 to make the plasmid pMYG1. Transformation of E. coli HB101 with pMYG1 resulted in a 6-fold increase in superoxide dismutase activity. There was also induction of Mn superoxide dismutase in the transformants upon exposure to paraquat, as evidenced by dramatically increased levels of the Mn superoxide dismutase polypeptide in cytoplasmic extracts and a 16-fold further increase in superoxide dismutase activity. As well, the E. coli transformants showed resistance to paraquat-mediated inhibition of growth. Anacystis nidulans, a cyanobacterium that has no detectable Mn superoxide dismutase and is, consequently, very sensitive to oxidative stress, was also transformed with pMYG1. The transformants had detectable levels of Mn superoxide dismutase protein and showed resistance to paraquat-mediated inhibition of growth and photobleaching of pigments. Paraquat is known to promote formation of the superoxide radical anion, O2-., and thus the data have been interpreted as indicating that the cloned Mn superoxide dismutase provides protection in both E. coli and A. nidulans against damage attributable to O2-.. 相似文献
55.
Broedl UC Maugeais C Millar JS Jin W Moore RE Fuki IV Marchadier D Glick JM Rader DJ 《Circulation research》2004,94(12):1554-1561
Endothelial lipase (EL) has been found to be a key enzyme in high-density lipoprotein (HDL) metabolism in mice, leading to the concept that inhibition of EL could be a novel strategy for raising HDL cholesterol levels. However, mice are "HDL animals" and the effect of EL on atherogenic apoB-containing lipoproteins has not been elucidated. We previously found that EL is capable of hydrolyzing very low-density lipoprotein (VLDL) and LDL lipids ex vivo. To investigate the role of EL in the metabolism of apoB-containing lipoproteins in vivo, we expressed human EL in three mouse models of elevated apoB-containing lipoproteins: apoE-deficient, LDL receptor-deficient, and human apoB transgenic mice. Unexpectedly, hepatic expression of EL resulted in markedly decreased levels of VLDL/LDL cholesterol, phospholipid, and apoB accompanied by significantly increased LDL apolipoprotein and phospholipid catabolism. To determine whether lipolytic activity is required for this effect, we also expressed a catalytically inactive form of human EL (ELS149A); unexpectedly, expression of ELS149A did not lower and in fact increased plasma lipids. Coexpression and coimmunoprecipitation studies suggested that catalytically inactive ELS149A inhibits endogenous mouse EL, accounting for the increased lipid levels. We conclude that (1) in addition to its known effects on HDL metabolism, EL influences the metabolism of apoB-containing particles; (2) catalytic activity of EL is required for its effects on apoB-containing lipoproteins; and (3) overexpressed catalytically inactive EL inhibits endogenous mouse EL, resulting in increased levels of plasma lipids. In light of these results, inhibition of EL has the potential to raise levels of atherogenic lipoproteins in addition to HDL-C levels. 相似文献
56.
Sterol carrier protein 2 gene transfer changes lipid metabolism and enterohepatic sterol circulation in mice 总被引:3,自引:0,他引:3
Zanlungo S Amigo L Mendoza H Miquel JF Vío C Glick JM Rodríguez A Kozarsky K Quiñones V Rigotti A Nervi F 《Gastroenterology》2000,119(6):1708-1719
BACKGROUND & AIMS: Sterol carrier protein 2 (SCP-2) enhances sterol cycling and facilitates cholesterol translocation between intracellular organelles and plasma membrane in cultured cells, including hepatocytes. We examined the role of SCP-2 in hepatic cholesterol and lipid trafficking through the sinusoidal and canalicular secretory pathways of the liver in vivo. METHODS: Recombinant adenovirus-mediated SCP-2 gene transfer was used to obtain hepatic overexpression of SCP-2 in C57BL/6 mice. RESULTS: SCP-2 overexpression in the mouse liver resulted in an 8-fold increase of SCP-2 protein levels and determined various effects on lipid metabolism. It decreased high-density lipoprotein cholesterol and increased low-density lipoprotein (LDL) cholesterol concentrations. The expressions of hepatic LDL receptor, apolipoprotein (apo) A-I, apoB, and apoE were decreased. SCP-2 overexpression also increased hepatic cholesterol concentration, associated with decreased cholesterol neosynthesis. Increased biliary cholesterol and bile acid secretion, bile acid pool size, and intestinal cholesterol absorption were also observed. CONCLUSIONS: These results indicate that modulation of SCP-2 expression in the liver determines important modifications on lipoprotein metabolism, hepatic cholesterol synthesis and storage, biliary lipid secretion, bile acid metabolism, and intestinal cholesterol absorption. 相似文献
57.
58.
Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes 总被引:3,自引:1,他引:3
Hepatic gene therapy could be used to treat a number of inherited blood diseases such as hemophilia or thrombophilia. Although liver-directed retroviral transduction can result in long-term gene expression in vivo, the low level of protein production has limited its clinical application. We reasoned that the insertion of liver-specific promoters into retroviral vectors would increase gene expression in vivo. The 347- bp human alpha 1-antitrypsin (hAAT), the 810-bp murine albumin (mAIb), the 490-bp rat phosphoenolpyruvate carboxykinase (rPECK), and the 596- bp rat liver fatty acid binding protein promoters were inserted into a Moloney murine leukemia retroviral backbone containing the hAAT reporter gene. Vectors that produced appropriately sized RNA and hAAT protein in vitro were tested in vivo by transducing regenerating rat livers. Long-term serum expression of the hAAT reporter gene was normalized to retroviral transduction efficiency as determined by using a polymerase chain reaction-based assay of genomic DNA from transduced rat livers. The hAAT, mAIb, and rPEPCK promoters were, respectively, 35- , 8-, and 0.02-fold as strong as the previously studied constitutive Pol-II promoter. We conclude that the hAAT promoter resulted in the highest expression from a retroviral vector and may result in therapeutically significant expression of other clinically significant blood proteins. 相似文献
59.
60.
Rosen Joseph G. Park Ju Nyeong Schneider Kristin E. White Rebecca Hamilton Beckham S. Wilson Glick Jennifer L. Footer Katherine H. A. Sherman Susan G. 《AIDS and behavior》2022,26(6):1992-2002
AIDS and Behavior - Despite growing availability, HIV pre-exposure prophylaxis (PrEP) uptake and adherence remains suboptimal among female sex workers (FSW) in the United States. Using... 相似文献